Archive for July 2023

Developers of innovative pharmaceuticals often face the challenge of healthcare systems that are not optimally designed to support the commercialization of their products. Advocacy, public affairs and policy shaping efforts aspire to address those challenges and drive change. In planning for the introduction of a new product, it is important to decouple aspirations regarding systemic…

The emergence of cell and gene therapies (CGTs) in the last decade has been one of the most captivating advancements in the field of life sciences. Chronic and fatal diseases that were once incurable can now be treated with a single administration. This almost resembles science fiction. While there have been numerous challenges to overcome…

In this decade, a significant revenue challenge awaits many leading pharmaceutical companies, as approximately half of the world’s top 20 drugs are expected to lose patent protection. To bridge this revenue gap, the industry will rely on new “blockbuster” launches. As a result, some of the leading pharma companies are starting to move away from…